Correspondence
To add the references below to your reference management program: 1. Download the file; 2. Open your reference management program or EndNote; 3. Select File and import |
90 Articles |
-
Reply to Correspondence: ‘Challenging the Frontier: Bridging Systemic Biomarkers and Small Airway Dynamics in Severe Asthma Management’
Contreras, N., Delgado-Dolset, M.I., Villaseñor, A. and Escribese, M.M. Allergy. First published: 20 June 2025
-
Correspondence: Cellular Rhinitis—A Key Yet Overlooked Factor in the Management of Otitis Media With Effusion (OME) and Eustachian Tube Dysfunction (ETD)
Gelardi, M. Allergy. First published: 27 May 2025
-
Correspondence to “Omalizumab Reduces Anaphylactic Reactions and Allows Food Introduction in Food-Allergic in Children With Severe Asthma: An Observational Study”
Klain, A., Indolfi, C., Grella, C., et al. Allergy. First published:17 April 2025
-
Reply to Correspondence: The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper
Agache, I., Adcock, I.M., Akdis, C.A., et al. Allergy. First published: 11 April 2025
-
Correspondence to ‘Interleukin-5 as a Pleiotropic Cytokine Orchestrating Airway Type 2 Inflammation: Effects on and Beyond Eosinophils’
McCrae, C., Jison, M.L. and Menzies-Gow, A. Allergy. First published: 10 April 2025
-
Correspondence: Causal Associations Between Chronic Spontaneous Urticaria and Thyroid Function Indicators in Different Ethnic Groups: A Bidirectional Two-Sample Mendelian Randomization Analysis
Zhang, Y., Zhou, J. and Ni, Y. Allergy. First published: 21 March 2025
-
Correspondence to “The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper”
Semenzato, U., Previtero, D., Padrin, Y., et al. Allergy. First published: 11 March 2025
-
Reply to Correspondence: What Is the Next Step for Patients With Aspirin-Exacerbated Respiratory Disease: Biologics With or Without Aspirin Therapy?
Doña, I., de Santa María, R.S., Moreno, E.M., et al. Allergy. First published: 06 March 2025
-
Correspondence: Epithelial Barrier Dysfunction: Do Not Forget Functional Dyspepsia!
Tack, J., Vanuytsel, T., Carbone, F., et al. Allergy. First published: 19 February 2025
-
Correspondence: “Challenging the Frontier: Bridging Systemic Biomarkers and Small Airway Dynamics in Severe Asthma Management”
Kotsiou, O.S., Kirgou, P., Siachpazidou, D., et al. Allergy. First published: 10 February 2025
-
What Is the Next Step for Patients With Aspirin-Exacerbated Respiratory Disease: Biologics With or Without Aspirin Therapy?
Szatkowski, P. and Mastalerz, L. Allergy. First published: 31 December 2024
-
Reply to correspondence to “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”
Bager, P., Wohlfahrt, J. and Melbye, M. Allergy. First published: 03 September 2024
-
Proposed amendment to the nomenclature of allergic diseases and hypersensitivity reactions: Looking beyond the classic paradigms
Mastalerz, L. Allergy. First published: 16 August 2024
-
Anaphylaxis and desensitization differently activate and induce IL-8 release by mast cells in a human peanut allergy in vitro model
Tontini, C., Bahri, R., Simpson, A. and Bulfone-Paus, S. Allergy. First published: 07 July 2024
-
Reply to correspondence: Correspondence to “the impact of indoor pollution on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma”
Canelo-Aybar, C., Nieto-Gutierrez, W., Rodriguez-Tanta, L.Y., et al. Allergy. First published: 16 June 2024
-
Correspondence to “Salivary Immunoinflammatory Proteins Identify Children with Eosinophilic Esophagitis”
Votto, M., Strisciuglio, C., Indolfi, C., et al. Allergy. First published: 04 June 2024
-
Correspondence to “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”
Porsbjerg, C., Fritzsching, B., Freemantle, N., et al. Allergy. First published: 05 May 2024
-
Oral immunotherapy in alpha-gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?
Ünal, D., Eyice-Karabacak, D., Kutlu, A., et al. Allergy. First published: 19 April 2024
-
Response to Correspondence to “Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy”
de Kam, P.J., Zielen, S., Bernstein, J.A., et al. Allergy. First published: 25 March 2024
Reply to the correspondence on “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”
et al. Allergy. First published: 10 March 2024
Correspondence to “intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL-6-mediated protection associated with cecal microbiota changes”
Chen, X. and He, Y.-q. Allergy. First published: 25 February 2024
Reply to Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—factor analysis”
Okada, N., Oguma, T. and Asano, K. Allergy. First published: 21 February 2024
Response to correspondence: Prediction of adult asthma risk in early childhood using novel adult asthma predictive risk scores
Farhan, A.J., Kothalawala, D.M., Kurukulaaratchy, R.J., et al. Allergy. First published: 08 February 2024
Correspondence to “Oral immunotherapy in alpha-gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?”
Chen, Y.-C., Lin, Y.-H., Lu, C.-T., Yii, C.-Y., Chen, P.-C. and Yong, S.-B. Allergy. First published: 13 February 2024
Reply to correspondence “Extracellular vesicle microRNA signatures as novel biomarkers in obese asthmatics”
Alhamdan, F., Potaczek, D.P., Greulich, T., Tost, J. and Garn, H. Allergy. First published: 29 January 2024
Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”
Chang, K.-Y., Lu, C.-T., Yii, C.-Y. and Yong, S.-B.Allergy. First published: 16 January 2024
Correspondence to “Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy1”
Cheng, I.-H., Yii, C.-Y., Shih, L.-C. and Yong, S.-B. Allergy. First published: 16 January 2024
Reply to “European academy of allergy and clinical immunology, food allergy, anaphylaxis guidelines group. EAACI guidelines: Anaphylaxis (2021 update)”
Barroso, B., Gómez-López, A., Betancor, D., et al. Allergy. First published: 12 January 2024
Extracellular vesicle microRNA signatures as novel biomarkers in obese asthmatics
Sundar, I.K., Prasad, C. and Duraisamy, S.K. Allergy. First published: 21 December 2023
Correspondence to ‘association between chronic rhinosinusitis and new onset asthma implications for prevention’
Cheng, I., Yii, C.-Y., Shih, et al. Allergy. First published: 01 December 2023
Correspondence to “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”
Ebo, D.G., Elst, J., Van Gasse, A.L., Mertens, C. and Sabato, V. Allergy. First published: 20 November 2023
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes
Zhang, D.G., Sørensen, J.A., Ghazanfar, M.N. and Thomsen, S.F. Allergy. First published: 15 November 2023
Response to “clinical applicability of the Urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes”
Gutsche, A., Salameh, P., Aulenbacher, F., et al. Allergy. First published: 03 November 2023
Sequential proteomic profiling of patients with Stevens–Johnson syndrome or toxic epidermal necrolysis
Contassot, E. and Brüggen, M.-C. Allergy. First published: 20 September 2023
Correspondence to “early infancy dysbiosis in food protein-induced enterocolitis syndrome: A prospective cohort study”
Hsu, Y.-S. and Yong, S.-B. Allergy. First published: 15 September 2023
Reply to correspondence to ‘Diagnosis of immediate reactions to amoxicillin: Comparison of basophil activation markers CD63 and CD203c in a prospective study’
Fernández, T.D., Mayorga, C. and Torres, M.J. Allergy. First published: 27 July 2023
Value of vaccine and vaccine excipient skin testing to COVID-19 vaccines
Brockow, K., Bent, R. and Biedermann, T. Allergy. First published: 30 June 2023
Practical conundrums of immune profiling in Stevens–Johnson syndrome-toxic epidermal necrolysis
Shah, S., Bishnoi, A., Vinay, K., et al. Allergy. First published: 14 June 2023
Reply to correspondence “Food allergens to emollients”
Irvine, A.D., Hourihane, J.O.B. and STOP-AD Team. Allergy. First published: 31 March 2023
Correspondence to “Diagnosis of immediate reactions to amoxicillin: Comparison of basophil activation markers CD63 and CD203c in a prospective study”
Elst, J., van der Poorten, M.-L.M., Toscano, A., et al. Allergy. First published: 30 March 2023
Importance of examining atopic dermatitis disease mechanisms in African populations
Lunjani, N., Akdis, C.A. and O'Mahony, L. Allergy. First published: 28 December 2022
Atopic dermatitis: The importance of future research in Africa
Fehr, D., Lang, C., Masenga, J., et al. Allergy. First published: 05 December 2022
COVID-19 pandemic and environment: Not only air pollution
Caminati, M., Guarnieri, G., Marchetti, P., et al. Allergy. First published: 28 November 2022
Basophil reactivity to BNT162b2 in COVID-19 convalescence
Perkins, G.B., Hurtado, P.R. and Hissaria, P. Allergy. First published: 28 November 2022
Reply to: “COVID-19 pandemic and environment: Not only air pollution.”
Fiorito, S., Soligo, M., Gao, Y., Ogulur, I., Akdis, C.A. and Bonini, S. Allergy. First published: 28 November 2022
Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm
Caminati, M., Feleszko, W., Michel, M., Annesi-Maesano, I., Vitte, J. Allergy. First published: 28 October 2022
Reply to “Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm”
Lukaszewicz, R., Mahay, G., Boyer, O. and Martinet, J. Allergy. First published: 28 October 2022
Is Helicobacter pylori infection inversely correlated with atopic, skin, and autoimmune diseases?
Yasuma, T., D’Alessandro-Gabazza, C.N., Fujimoto, H., et al. Allergy. First published: 28 September 2022
Reply to correspondence: “Is Helicobacter pylori infection inversely correlated with atopic, skin, and autoimmune diseases?”
Lee, H., Cho, S.I., Yang, M.-S., Cho, S.-J. and Lee, D.H. Allergy. First published: 28 September 2022
Correspondence to “Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus”
Smith, P.K., Lesslar, O. and Price, D.B. et al. Allergy. First published: 06 August 2022
Reply to correspondence to ‘Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus’
Hagemann, J., Zuberbier, T., Walter Canonica, G., et al. Allergy. First published: 06 August 2022
Bacillus Calmette–Guérin vaccination to prevent childhood asthma: A revised meta-analysis
Pittet, L.F. and Curtis, N. Allergy. First published: 30 June 2022
Reply to correspondence: Basophil reactivity to BNT162b2 in COVID-19 convalescence
Labella, M., Céspedes, J.A., Doña, I., et al. Allergy. First published: 30 June 2022
Comment on EAACI guideline: Anaphylaxis (2021 update)
Miceli Sopo, S., Sinatti, D., Mastellone, F., Bersani, G. and Gelsomino, M. et al. Allergy. First published: 30 June 2022
Reply to the correspondence: Bacillus Calmette-Guérin vaccination to prevent childhood asthma—A revised analysis
Navaratna, S., Burgess, J., Waidyatillake, N., et al. Allergy. First published: 30 June 2022
Reply to: “Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients”
Renert-Yuval, Y. and Guttman-Yassky, E. Allergy. First published: 30 June 2022
Correspondence to " Emollients in infancy to prevent atopic dermatitis: A systematic review and meta-analysis"
Kelleher, M.M., Cro, S., Phillips, R., et al. Allergy. First published: 29 May 2022
Reply to correspondence: Emollients in infancy to prevent atopic dermatitis: A systematic review and meta-analysis
Zhong, Y., Samuel, M., van Bever, H. and Tham, E.H. Allergy. First published: 29 May 2022
Food-induced immediate response of the esophagus: A first report in the pediatric age
Votto, M., Naso, M., De Filippo, M., et al. Allergy. First published: 24 January 2022
Successful administration of second dose of BNT162b2 COVID-19 vaccine in two patients with potential anaphylaxis to first dose
Cahill, J.A. and Kan, M.sss Allergy. First published: 29 December 2021
β2-adrenergic agonists and doping: Where do we stand?
Lourenço, O., Cardoso, A., Mónico, B., Gama, J.M.R., Neiva, H.P. and Marinho, D.A. Allergy. 2021; 76: 2320-2321
Role of activation of the coagulation system in the pathogenesis of urticaria
Yasuma, T., D’Alessandro-Gabazza, C.N., Kobayashi, T., Morser, J. and Gabazza, E.C. Allergy. 2021; 76: 3243-3244
Silicosis: Pathogenesis and utility of animal models of disease
Walters, E.H. and Shukla, S.D. Allergy. 2021; 76: 3241-3242
Beta2-adrenergic agonists can enhance intense performance and muscle strength in healthy individuals
Hostrup, M., Jessen, S., Backer, V., Bangsbo, J. and Jacobson, G.A. Allergy. 2021; 76: 2318-2319
COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: “Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines”
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1943-1944
Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines
Borgsteede, S.D., Geersing, T.H. and Tempels-Pavlica, Ž. Allergy. 2021; 76: 1941-1942
COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: “COVID-19 vaccine anaphylaxis: PEG or not?”
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1938-1940
COVID-19 vaccine anaphylaxis: PEG or not?
Krantz, M.S., Liu, Y., Phillips, E.J. and Stone, C.A., Jr Allergy. 2021; 76: 1934-1937
Successful rapid desensitization in a glioma patient with procarbazine-mediated anaphylaxis
Hutten, E.M., Lambeck, A.J.A., Dijkstra, H., et al. Allergy. 2021; 76: 1932-1933
Reply to “Acute scrotum in a 8- year- old Italian child caused by extraintestinal anisakiasis in a seaside area
Morishima, R. Allergy. 2021; 76: 1603-1603
Acute scrotum in a 8-year-old Italian child caused by extraintestinal anisakiasis in a seaside area
Centonze, A., Capillo, S., Mazzei, A., et al. Allergy. 2021; 76: 1601-1602
Reply to: “Include desensitization to radiocontrast media in the diagnostic algorithm”
Brockow, K. Allergy. 2021; 76: 1304-1305
Include desensitization to radiocontrast media in the diagnostic algorithm of radio contrast media hypersensitivity
Bjørbak Alnæs, M. Allergy. 2021; 76: 1302-1303
Reply to “Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy”
Stranzl, T., Ipsen, H., Christensen, L.H., et al. Allergy. 2021; 76: 1300-1301
Inferring clinical relevance of Der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy
González-Pérez, R. and Poza-Guedes, P. Allergy. 2021; 76: 1298-1299
Asthmatic patients and COVID-19: Different disease course?
Alberca, R.W., Yendo, T., Aoki, V. and Sato, M.N. Allergy.2021; 76: 963-965
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?
Heffler, E., Detoraki, A., Contoli, M., et al. Allergy.2021; 76: 961-962
Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?
Kow, C.S., Capstick, T. and Hasan, S.S. Allergy.2021; 76: 959-960
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology
Bhalla, A., Mukherjee, M., Radford, K., et al. Allergy.2021; 76: 957-958
Asthma phenotypes, comorbidities, and disease activity in COVID-19: The need of risk stratification
Carli, G., Cecchi, L., Stebbing, J., Parronchi, P. and Farsi, A. Allergy.2021; 76: 955-956
Update on asthma prevalence in severe COVID-19 patients
Morais-Almeida, M., Barbosa, M.T., Sousa, C.S., Aguiar, R. and Bousquet, J. Allergy.2021; 76: 953-954
Comment on: Bilò MB, Pravettoni V, Mauro M, Bonadonna P. Treating venom allergy during COVID-19 pandemic
Martínez-Lourido, E., Otero, A., Armisén, M. and Vidal, C. Allergy, 76: 951-952
Treating venom allergy during COVID-19 pandemic
Bilò, M.B., Pravettoni, V., Mauro, M. and Bonadonna, P. Allergy.2021; 76: 949-950
Reply to Dr. Vincenzo Patella et al. Could anti-tubercular vaccination protect against COVID-19 infection?
Ozdemir, C., Kucuksezer, U.C. and Tamay, Z.Ü. Allergy. 2021; 76: 946-948
Could anti-tubercular vaccination protect against COVID-19 infection?
Patella, V., Florio, G., Brancaccio, R. and Delfino, G. Allergy.2021; 76: 942-945
Reply to correspondence: Silica-related diseases in the modern world: A role for self-DNA sensing in lung inflammatory
Chambers, D.C. and Hoy, R.F. Allergy.2020; 75: 3011-3011
Silica-related diseases in the modern world: A role for self-DNA sensing in lung inflammatory diseases
Togbe, D., Benmerzoug, S., Jacobs, M., Ryffel, B. and Quesniaux, V.F.J. Allergy.2020; 75: 3009-3010
Preschool wheeze: Challenges and research prospects reply to: Dr Jartti and Colleagues; in response to our manuscript entitled: Medical algorithm: Diagnosis and treatment of preschool asthma
Bush, A. and Saglani, S. Allergy. 2020; 75: 2718-2718
Reply to: Medical algorithm: Diagnosis and treatment of preschool asthma
Jartti, T., Papadopoulos, N.G., Feleszko, W. Allergy.2020; 75: 2716-2717
Detection of peanut allergens in serum: circumventing the inhibitory effect of immunoglobulins
Koppelman, S.J., Witteveen, M., JanssenDuijghuijsen, L., Baumert, J.L., Witkamp, R.F. and van Norren, K. Allergy.2020; 75: 1835-1836
Relationship between early pubertal maturation and asthma: The role of adiposity rebound in early childhood
Chen, Y.-C. and Lee, Y.L. Allergy.2020; 75: 999-1000
Relationship between early pubertal maturation and asthma
Ichikawa, G., Arisaka, O., Nakayama, K., Koyama, S. and Yoshihara, S. Allergy.2020; 75: 998-998
Reply to correspondence: "Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments"
Manti, S., Licari, A., Leonardi, S., Marseglia, G.L. and Baraldi, E. Allergy.2020; 75: 1531-1532
Correspondence to "Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments"
Jartti, T., Smits, H.H., Bønnelykke, K., et al. Allergy.2020; 75: 1529-1530
Reply to: "Arginase inhibitors: An alternative in treatment of obese asthma?"
Meurs, H., Zaagsma, J., Maarsingh, H. and van Duin, M. Allergy.2020; 75: 1527-1528
Arginase inhibitors: An alternative in treatment of obese asthma?
Felix, M.M.R. and Kuschnir, F.C. Allergy.2020; 75: 1525-1526
Role of routine cephalosporin allergy testing in surgical site infection reduction bundles
Fox, W.E. and Scott, M.J.Allergy.2019; 74: 1820-1820
Stability of neuromuscular blocking drugs used for skin testing
Baldo B. A. Allergy.2019; 74: 1201-1202